Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries

Background—The existence of circulating endothelial progenitor cells (CEPCs) has previously been documented. These cells can be mobilized by cytokines and are recruited to sites of injury, where they may participate in tissue repair. In the present study, we examined the hypothesis that mobilization of CEPCs by exogenous granulocyte-colony stimulating factor (G-CSF) enhances repair of injured arteries by facilitating reendothelialization and inhibiting neointima development. Methods and Results—Male rats were injected daily with 50 &mgr;g/kg recombinant human G-CSF or 0.9% NaCl SC for 8 days. On the fifth day of treatment, 1 mL of blood was collected for fluorescence-activated cell sorting analysis of mononuclear cells, and the animals underwent balloon angioplasty of the common carotid artery. The animals were killed at 2 or 4 weeks after injury, and the carotid arteries were harvested and processed for immunohistochemistry, scanning electron microscopy (SEM), and morphometric analysis of endothelialization and neointimal formation. G-CSF increased the number of circulating mononuclear cells that express endothelial cell lineage markers several-fold. SEM and immunohistochemical staining with the endothelial marker, platelet and endothelial cell adhesion molecule-1, showed rapid and nearly complete (>90%) reendothelialization of the denuded vessels in the G-CSF–treated animals compared with <20% in the control animals. Reendothelialization was paralleled by a decrease in inflammation in the vessel wall. Neointima thickness was reduced by ≈60% in the G-CSF–treated animals compared with control animals at 2 and 4 weeks after injury. Conclusion—We postulate that cytokine-induced mobilization of CEPCs may be a suitable therapeutic strategy for prevention of restenosis after revascularization procedures.

[1]  R. Mulligan,et al.  Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular Therapy , 2003, Circulation.

[2]  U. Laufs,et al.  Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury , 2003, Circulation research.

[3]  P. Ganz,et al.  Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.

[4]  N. Caplice,et al.  Smooth Muscle Progenitor Cells in Human Blood , 2002, Circulation.

[5]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[6]  J. Isner,et al.  Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells , 2002, Circulation.

[7]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[8]  L. Sauvage,et al.  Utilizing Granulocyte Colony-stimulating Factor to Enhance Vascular Graft Endothelialization from Circulating Blood Cells , 2002, Annals of vascular surgery.

[9]  J. Isner,et al.  Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration , 2002, Circulation.

[10]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[11]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[12]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[13]  L. Sauvage,et al.  Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. , 2000, Journal of vascular surgery.

[14]  J. Isner,et al.  Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. , 2000, Circulation research.

[15]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[16]  J. Tisdale,et al.  Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. , 1998, Blood.

[17]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[18]  T. Hartung,et al.  Anti‐inflammatory effects of granulocyte colony‐stimulating factor , 1998, Current opinion in hematology.

[19]  R. Schwartz,et al.  Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. , 1998, The American journal of cardiology.

[20]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[21]  S. Sartore,et al.  Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. , 1994, Clinical science.

[22]  A. Mantovani,et al.  Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.